Helmerich & Payne (NYSE:HP) Bolsa

HELMERICH & PAYNE

Helmerich & Payne

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Susquehanna analyst Charles Minervino maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Positive and lowers the price target from $24 to $23.

News

Price Target

Analyst Ratings

Susquehanna Maintains Positive on Helmerich & Payne, Lowers Price Target to $23

Citigroup analyst Scott Gruber maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $19 to $17.

Citigroup Maintains Neutral on Helmerich & Payne, Lowers Price Target to $17

Goldman Sachs analyst Neil Mehta maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sell and lowers the price target from $25 to $17.

Goldman Sachs Maintains Sell on Helmerich & Payne, Lowers Price Target to $17

10 analysts have expressed a variety of opinions on Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $23.0, a high estimate of $32.00, and a low estimate of $17.00. A 20.69% drop is evident in the current average compared to the previous average price target of $29.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750424465_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Helmerich &amp; Payne's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Sean Meakim</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$28.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Helmerich &amp; Payne's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Helmerich &amp; Payne's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
<h3>Unraveling the Financial Story of Helmerich &amp; Payne</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Helmerich &amp; Payne's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 47.69%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Helmerich &amp; Payne's net margin excels beyond industry benchmarks, reaching 0.12%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Helmerich &amp; Payne's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.04%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Helmerich &amp; Payne's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.02%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.76.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Helmerich & Payne's Future

Barclays analyst David Anderson maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Equal-Weight and lowers the price target from $20 to $17.

Barclays Maintains Equal-Weight on Helmerich & Payne, Lowers Price Target to $17

JP Morgan analyst Sean Meakim maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $25 to $17.

JP Morgan Maintains Neutral on Helmerich & Payne, Lowers Price Target to $17

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">FLEX LNG Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLNG#NYSE">FLNG</a>)</h3>
<ul class="wp-block-list">
<li>On May 21, Flex LNG posted better-than-expected quarterly earnings. Marius Foss, Interim CEO of Flex LNG Management AS, said, &#8220;Flex LNG delivered solid results for the first quarter, with revenues of $88.4 million, or $86.8 million excluding EUAs. Net income came in at $18.7 million, translating to earnings per share (EPS) of $0.35 and adjusted net income came in at $29.4 million, or $0.54 per share. As expected, revenue decreased by $3 million compared to Q4 2024 primarily due to lower earnings from Flex Artemis, operating on a variable index hire.&#8221; The company's stock fell around 9% over the past five days and has a 52-week low of $19.46.</li>
<li>RSI Value: 27.9</li>
<li>FLNG Price Action: Shares of FLEX LNG fell 8.2% to close at $22.39 on Wednesday.</li>
<li>Edge Stock Ratings: 24.66 Momentum score with Value at 71.53. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/FLNG"><img loading="lazy" decoding="async" width="486" height="183" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044048/image-277.png" alt="" class="wp-image-924003" style="width:316px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044048/image-277.png 486w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044048/image-277-300x113.png 300w" sizes="(max-width: 486px) 100vw, 486px" /></a></figure>
<h3 class="wp-block-heading">Helmerich and Payne Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 19, Citigroup analyst Scott Gruber downgraded Helmerich &amp; Payne from Buy to Neutral and lowered the price target from $25 to $19. The company's stock fell around 23% over the past month and <a href="https://www.benzinga.com/quote/HP">has a 52-week low</a> of $15.21.</li>
<li>RSI Value: 23.1</li>
<li>HP Price Action: Shares of Helmerich and Payne fell 5.6% to close at $15.21 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0522">HP stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0522"><img loading="lazy" decoding="async" width="927" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044147/image-278.png" alt="" class="wp-image-924007" style="width:622px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044147/image-278.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044147/image-278-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22044147/image-278-768x698.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Ring Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REI#NYSE">REI</a>)</h3>
<ul class="wp-block-list">
<li>On May 7, Ring Energy posted weaker-than-expected quarterly earnings. Mr. Paul D. McKinney, Chairman of the Board and Chief Executive Officer, commented, &#8220;We&#8217;re excited to kick off 2025 with a strong first quarter, showcasing the flexibility, resilience, and strength of our proven, value-focused strategy amid fluctuating oil prices. Our performance met or surpassed all guidance targets, driven by exceptional oil sales volumes.&#8221; The company's stock fell around 15% over the past five days and has a 52-week<a href="https://www.benzinga.com/quote/REI"> low of $0.74</a>.</li>
<li>RSI Value: 29.9</li>
<li>REI Price Action: Shares of Ring Energy fell 4.2% to close at $0.75 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0522"> REI shares</a>.</li>
</ul>
How do other stocks rank? Get the full <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">BZ Edge Rankings breakdown here</a>.
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/25/05/45540545/jim-cramer-recommends-not-buying-mosaic-doesnt-like-this-industrial-stock">Jim Cramer Recommends Not Buying Mosaic, Doesn&#8217;t Like This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

FLNG

Top 3 Energy Stocks That Could Lead To Your Biggest Gains This Quarter

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Seaport Global analyst David Joyce initiated coverage on Starz Entertainment Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRZ#NASDAQ">STRZ</a>) with a Buy rating and announced a price target of $30. Starz Entertainment shares closed at $13.01 on Friday. <a href="https://www.benzinga.com/quote/strx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barrington Research analyst Kevin Steinke initiated coverage on Mobile Infrastructure Corporation (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) with an Outperform rating and announced a price target of $6.5. Mobile Infrastructure shares closed at $3.76 on Friday. <a href="https://www.benzinga.com/quote/beep/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying STRZ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="607" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-1024x607.png" alt="" class="wp-image-919755" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-1024x607.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-768x455.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Initiation

Mobile Infrastructure Corporation Common Stock

BEEP

NFLX

RDDT

STRZ

This Starz Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>TD Securities analyst Andrew Charles downgraded the rating for Shake Shack Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) from Buy to Hold and maintained the price target of $105. Shake Shack shares closed at $119.19 on Friday. <a href="https://www.benzinga.com/quote/SHAK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Giacomo Romeo downgraded the rating for BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from Buy to Hold and lowered the price target from $40.8 to $29. BP shares closed at $29.76 on Friday. <a href="https://www.benzinga.com/quote/BP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Doug Anmuth downgraded Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) from Overweight to Neutral but raised the price target from $1,150 to $1,220. Netflix shares closed at $1,191.53 on Friday. <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Scott Gruber downgraded the rating for Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) from Buy to Neutral and lowered the price target from $25 to $19. Helmerich &amp; Payne shares closed at $17.80 on Friday. <a href="https://www.benzinga.com/quote/HP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Ken Gawrelski downgraded Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) from Overweight to Equal-Weight and lowered the price target from $168 to $115. Reddit shares closed at $113.23 on Friday. <a href="https://www.benzinga.com/quote/RDDT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="593" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19080745/image-229-1024x593.png" alt="" class="wp-image-919713" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19080745/image-229-1024x593.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19080745/image-229-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19080745/image-229-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19080745/image-229.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Downgrades

SHAK

This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Needham raised ACADIA Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) price target from $27 to $30. Needham analyst Ami Fadia maintained a Buy rating. ACADIA Pharmaceuticals shares closed at $22.26 on Friday. <a href="https://www.benzinga.com/quote/ACAD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies cut the price target for BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from $40.8 to $29. Jefferies analyst Giacomo Romeo downgraded the stock from Buy to Hold. BP shares closed at $29.76 on Friday. <a href="https://www.benzinga.com/quote/BP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan boosted Marqeta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) price target from $5 to $6. JP Morgan analyst Tien-Tsin Huang upgraded the stock from Neutral to Overweight. Marqeta shares closed at $5.04 on Friday. <a href="https://www.benzinga.com/quote/MQ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised the price target for Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) from $1,150 to $1,220. JP Morgan analyst Doug Anmuth downgraded the stock from Overweight to Neutral. Netflix shares closed at $1,191.53 on Friday. <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised the price target for Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) from $131 to $166. Barclays analyst Seth Sigman upgraded the stock from Underweight to Equal-Weight. Williams-Sonoma shares closed at $173.84 on Friday. <a href="https://www.benzinga.com/quote/WSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. raised ACADIA Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) price target from $27 to $32. HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating. ACADIA Pharmaceuticals shares settled at $22.26 on Friday. <a href="https://www.benzinga.com/quote/ACAD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital raised Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) price target from $430 to $510. Loop Capital analyst Alan Gould upgraded the stock from Hold to Buy. Charter Communications shares closed at $427.25 on Friday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) price target from $25 to $19. Citigroup analyst Scott Gruber downgraded the stock from Buy to Neutral. Helmerich &amp; Payne shares closed at $17.80 on Friday.  <a href="https://www.benzinga.com/quote/HP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS increased the price target for Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) from $46 to $66. UBS analyst Thomas Wadewitz upgraded the stock from Neutral to Buy. Delta Air Lines shares settled at $50.92 on Friday. <a href="https://www.benzinga.com/quote/DAL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS raised Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) price target from $55 to $60. UBS analyst Manav Gupta upgraded the stock from Neutral to Buy. Archer-Daniels-Midland shares closed at $50.13 on Friday. <a href="https://www.benzinga.com/quote/adm/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NFLX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19075050/image-226-1024x598.png" alt="" class="wp-image-919670" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19075050/image-226-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19075050/image-226-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19075050/image-226-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19075050/image-226.png 1121w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

ACAD

CHTR

Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday

Citigroup analyst Scott Gruber downgrades Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) from Buy to Neutral and lowers the price target from $25 to $19.

Citigroup Downgrades Helmerich & Payne to Neutral, Lowers Price Target to $19

Morgan Stanley analyst Daniel Kutz maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Underweight and lowers the price target from $27 to $20.

Morgan Stanley Maintains Underweight on Helmerich & Payne, Lowers Price Target to $20

Ratings for Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $25.86, a high estimate of $32.00, and a low estimate of $20.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 22.41%. 
<img src="https://www.benzinga.com/files/images/story/2025/1747245653_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Helmerich &amp; Payne is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$28.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Daniel Kutz</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$24.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Helmerich &amp; Payne's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Helmerich &amp; Payne's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
<h3>Financial Insights: Helmerich &amp; Payne</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Helmerich &amp; Payne displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 50.01%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Helmerich &amp; Payne's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 0.16%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Helmerich &amp; Payne's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.06%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Helmerich &amp; Payne's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.03%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.76.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Helmerich & Payne Stock

Barclays analyst David Anderson maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Equal-Weight and lowers the price target from $24 to $20.

Barclays Maintains Equal-Weight on Helmerich & Payne, Lowers Price Target to $20

Citigroup analyst Scott Gruber maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Buy and lowers the price target from $32 to $25.

Citigroup Maintains Buy on Helmerich & Payne, Lowers Price Target to $25

Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.68 by 97.06 percent. This is a 97.62 percent decrease over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $1.02 billion which beat the analyst consensus estimate of $938.57 million by 8.25 percent. This is a 47.69 percent increase over sales of $687.94 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Helmerich & Payne Q2 Adj. EPS $0.02 Misses $0.68 Estimate, Sales $1.02B Beat $938.57M Estimate

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

Throughout the last three months, 7 analysts have evaluated Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $30.0, a high estimate of $39.00, and a low estimate of $24.00. A 22.74% drop is evident in the current average compared to the previous average price target of $38.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1744657261_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Helmerich &amp; Payne among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Charles Minervino &#x7C;Susquehanna &#x7C;Lowers &#x7C;Positive &#x7C; $28.00&#x7C;$43.00 &#x7C; 
&#x7C;Neil Mehta &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $25.00&#x7C;$32.00 &#x7C; 
&#x7C;Scott Gruber &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $32.00&#x7C;$33.00 &#x7C; 
&#x7C;Daniel Kutz &#x7C;Morgan Stanley &#x7C;Announces &#x7C;Underweight &#x7C; $27.00&#x7C;- &#x7C; 
&#x7C;David Anderson &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $24.00&#x7C;$36.00 &#x7C; 
&#x7C;Keith Mackey &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $35.00&#x7C;$41.00 &#x7C; 
&#x7C;James West &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;In-Line &#x7C; $39.00&#x7C;$48.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Helmerich &amp; Payne. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Helmerich &amp; Payne's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Helmerich &amp; Payne's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Helmerich &amp; Payne Better</h2>
Helmerich &amp; Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
<h3>Helmerich &amp; Payne's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Helmerich &amp; Payne's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.02% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Helmerich &amp; Payne's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 7.97%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Helmerich &amp; Payne's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.84% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Helmerich &amp; Payne's ROA stands out, surpassing industry averages. With an impressive ROA of 0.93%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.6, Helmerich &amp; Payne adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Helmerich & Payne Through 7 Analysts

Susquehanna analyst Charles Minervino maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Positive and lowers the price target from $43 to $28.

Susquehanna Maintains Positive on Helmerich & Payne, Lowers Price Target to $28

Goldman Sachs analyst Neil Mehta maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sell and lowers the price target from $32 to $25.

Goldman Sachs Maintains Sell on Helmerich & Payne, Lowers Price Target to $25

Press Releases

Helmerich & Payne, Inc. Announces Fiscal Fourth Quarter & Fiscal Year Results

Helmerich & Payne, Inc. Announces Release of its 2024 Sustainability Report

Helmerich & Payne, Inc. Announces Fiscal First Quarter 2025 Conference Call and Webcast

Helmerich & Payne Completes Acquisition of KCA Deutag

Helmerich & Payne, Inc. Announces Fiscal First Quarter Results

Helmerich & Payne, Inc. To Participate in Conferences in March 2025

Helmerich & Payne, Inc. Announces Fiscal Second Quarter 2025 Conference Call and Webcast

Helmerich & Payne, Inc. Announces Fiscal Second Quarter Results

H&P Retains Eastdil Secured to Evaluate Future Options for Utica Square Shopping Center

Comments

Helmerich & Payne

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL